SlideShare uma empresa Scribd logo
1 de 23
Take two apps and call me in
the morning
Prescribing code instead of pills, clinician
perspective
 Joel M Topf, MD
 @Kidney_boy
 @eajkd
 www.Pbfluids.com
Kidometer
KDIGO iPad app
UK Prospective Diabetes Study
An intensive glucose control policy HbA1c 7.0 % vs 7.9 %
reduces risk of
◦ any diabetes-related endpoints 12% p=0.030
◦ microvascular endpoints 25% p=0.010
◦ myocardial infarction 16% p=0.052
A tight blood pressure control policy 144/82 vs 154/87
mmHg reduces risk of
◦ any diabetes-related endpoint 24% p=0.005
◦ microvascular endpoint 37% p=0.009
◦ stroke 44% p=0.013
The benefit from tight glycemic
control is less than the benefit
from lousy blood pressure control
Blood pressure control is more
important blood sugar control
525,600minutes in a year
minutes are
assessed with
office BP
Gold standard for blood pressure
assessment is 24-hour
ambulatory blood pressure
monitoring
Patient assessed home blood
pressures are more than twice
as correlated than physician
measured office blood
pressures.
Home 0.56
Office (MD) 0.21
Office (RN) 0.31
Little P, et al. BMJ. Aug 3 2002;325(7358):
Home blood pressure
readings are better than office
readings at predicting end-
organ damage (left ventricular
hypertrophy, atherosclerosis),
cardiovascular events and
total mortality
but this amazing technology is
useless if you forget your numbers…
…no patient ever
forgets her phone
Easiest blood pressure diary is
the camera phone
• No app to download
• You already know how to use it
• No cheating
• Time and date stamped
Can we go further?
 Patients titrate insulin based on blood
sugar
 Can patients titrate antihypertensive
medications based on blood
pressure?
152.1
139
134.9
151.8
142.4
140.1
125
130
135
140
145
150
155
Baseline 6 Months 12 Months
Systolic Blood Pressure
Intervention Control
85
79.6
77.4
84.5
80.3
79.5
72
74
76
78
80
82
84
86
Baseline 6 Months 12 Months
Diastolic Blood Pressure
The intervention group
 more medications prescribed
(p=0.001)
◦ 0.3 at 6 months
◦ 0.4 at 12 months
 fewer clinic visits (NS)
◦ 3.2 visits versus 3.5 for the control group
 improved quality of life (NS)
PatientswithEvents(%)
0
5
10
15
20
Years Post-Randomization
0 1 2 3 4 5 6 7 8
Primary Outcome
Nonfatal MI, Nonfatal Stroke or CVD Death
HR = 0.88
95% CI (0.73-1.06)
We pay for tight blood
pressure control with acute
renal failure, hypotension and
What I want in a prescription app
 Public algorithm
 Partners with the physician to choose
the appropriate titration strategy
 Validated
 Approved

Mais conteúdo relacionado

Mais procurados

Identifying and Managing Hyperglycaemia in Acute Coronary Syndromes
Identifying and Managing Hyperglycaemia in Acute Coronary SyndromesIdentifying and Managing Hyperglycaemia in Acute Coronary Syndromes
Identifying and Managing Hyperglycaemia in Acute Coronary Syndromes
PeninsulaEndocrine
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
ueda2015
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
ueda2015
 
ADVANCE - Type 2 diabetes - vascular risk with intervention
ADVANCE - Type 2 diabetes - vascular risk with interventionADVANCE - Type 2 diabetes - vascular risk with intervention
ADVANCE - Type 2 diabetes - vascular risk with intervention
PeninsulaEndocrine
 
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with interventionDCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
PeninsulaEndocrine
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
MedicineAndHealthUSA
 

Mais procurados (20)

Early Treatment of Atrial Fibrillation (AF) - By Dr Pipin Kojodjojo
Early Treatment of Atrial Fibrillation (AF) - By Dr Pipin KojodjojoEarly Treatment of Atrial Fibrillation (AF) - By Dr Pipin Kojodjojo
Early Treatment of Atrial Fibrillation (AF) - By Dr Pipin Kojodjojo
 
Cvd risk in dm
Cvd risk in dmCvd risk in dm
Cvd risk in dm
 
How to link glucose control to cv outcomes
How to link glucose control to cv outcomesHow to link glucose control to cv outcomes
How to link glucose control to cv outcomes
 
Identifying and Managing Hyperglycaemia in Acute Coronary Syndromes
Identifying and Managing Hyperglycaemia in Acute Coronary SyndromesIdentifying and Managing Hyperglycaemia in Acute Coronary Syndromes
Identifying and Managing Hyperglycaemia in Acute Coronary Syndromes
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
 
ADVANCE - Type 2 diabetes - vascular risk with intervention
ADVANCE - Type 2 diabetes - vascular risk with interventionADVANCE - Type 2 diabetes - vascular risk with intervention
ADVANCE - Type 2 diabetes - vascular risk with intervention
 
New horizons in ckd management
New horizons in ckd managementNew horizons in ckd management
New horizons in ckd management
 
Effects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitusEffects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitus
 
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with interventionDCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
 
Drug induced diabetes
Drug induced diabetesDrug induced diabetes
Drug induced diabetes
 
Management of cad in diabetes
Management of cad in diabetesManagement of cad in diabetes
Management of cad in diabetes
 
Should Fenofibrate be prescribed to all Diabetics?
Should Fenofibrate be prescribed to all Diabetics?Should Fenofibrate be prescribed to all Diabetics?
Should Fenofibrate be prescribed to all Diabetics?
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)
 
ueda2012 advance trial-d.salah
ueda2012 advance trial-d.salahueda2012 advance trial-d.salah
ueda2012 advance trial-d.salah
 
Dm and kidney August 23 2019
Dm and kidney August 23 2019Dm and kidney August 23 2019
Dm and kidney August 23 2019
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
 
ueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahedueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahed
 
New Approaches To The Treatment Of Hyperphosphataemia (CRF)
New Approaches To The Treatment Of Hyperphosphataemia (CRF)New Approaches To The Treatment Of Hyperphosphataemia (CRF)
New Approaches To The Treatment Of Hyperphosphataemia (CRF)
 

Destaque

Destaque (8)

Funkhaus Regensburg, Harry Landauer, Lokalrundfunktage 2014
Funkhaus Regensburg, Harry Landauer, Lokalrundfunktage 2014Funkhaus Regensburg, Harry Landauer, Lokalrundfunktage 2014
Funkhaus Regensburg, Harry Landauer, Lokalrundfunktage 2014
 
MMD16 - Prof. Erich Schöls - Zwischen Wirklichkeit und Fiktion
MMD16 - Prof. Erich Schöls - Zwischen Wirklichkeit und FiktionMMD16 - Prof. Erich Schöls - Zwischen Wirklichkeit und Fiktion
MMD16 - Prof. Erich Schöls - Zwischen Wirklichkeit und Fiktion
 
MMD16 - Duygu Gezen - Snapchat Storytelling
MMD16 - Duygu Gezen - Snapchat StorytellingMMD16 - Duygu Gezen - Snapchat Storytelling
MMD16 - Duygu Gezen - Snapchat Storytelling
 
MMD 16 - Sandra Cortesi - Youth and Online News
MMD 16 - Sandra Cortesi - Youth and Online NewsMMD 16 - Sandra Cortesi - Youth and Online News
MMD 16 - Sandra Cortesi - Youth and Online News
 
MMD16 - Dr. Astrid Carolus - Smartphones als digitale Begleiter
MMD16 - Dr. Astrid Carolus - Smartphones als digitale BegleiterMMD16 - Dr. Astrid Carolus - Smartphones als digitale Begleiter
MMD16 - Dr. Astrid Carolus - Smartphones als digitale Begleiter
 
MMD16 - Gudrun Riedl - 360° Video BR24
MMD16 - Gudrun Riedl - 360° Video BR24MMD16 - Gudrun Riedl - 360° Video BR24
MMD16 - Gudrun Riedl - 360° Video BR24
 
MMD16 - Aline Buttkereit - Virtual Reality
MMD16 - Aline Buttkereit - Virtual RealityMMD16 - Aline Buttkereit - Virtual Reality
MMD16 - Aline Buttkereit - Virtual Reality
 
MMD16 - Martin Hoffmann - Die News Roboter kommen!
MMD16 - Martin Hoffmann - Die News Roboter kommen!MMD16 - Martin Hoffmann - Die News Roboter kommen!
MMD16 - Martin Hoffmann - Die News Roboter kommen!
 

Semelhante a Prescribing an app

Is early use of combination therapy the solution 35 minute slide set
Is early use of combination therapy the solution   35 minute slide setIs early use of combination therapy the solution   35 minute slide set
Is early use of combination therapy the solution 35 minute slide set
SoM
 
12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx
12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx
12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx
AkhilSharma221092
 
Van Gelder Race
Van Gelder RaceVan Gelder Race
Van Gelder Race
enforme
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
Phil Boehmer
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
Phil Boehmer
 
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
brnmomentum
 

Semelhante a Prescribing an app (20)

Is early use of combination therapy the solution 35 minute slide set
Is early use of combination therapy the solution   35 minute slide setIs early use of combination therapy the solution   35 minute slide set
Is early use of combination therapy the solution 35 minute slide set
 
Three Dimensions of Care for Diabetes (3DFD) – diabetes management for people...
Three Dimensions of Care for Diabetes (3DFD) – diabetes management for people...Three Dimensions of Care for Diabetes (3DFD) – diabetes management for people...
Three Dimensions of Care for Diabetes (3DFD) – diabetes management for people...
 
12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx
12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx
12 Reasons to Prescribe Ticagrelor & Affordability of Generics.pptx
 
Van Gelder Race
Van Gelder RaceVan Gelder Race
Van Gelder Race
 
Novedades en farmacología en intervencionismo
Novedades en farmacología en intervencionismoNovedades en farmacología en intervencionismo
Novedades en farmacología en intervencionismo
 
Journal club
Journal clubJournal club
Journal club
 
Dm medications cv safety
Dm medications cv safetyDm medications cv safety
Dm medications cv safety
 
1120310-最新台灣高血壓治療指引.pdf
1120310-最新台灣高血壓治療指引.pdf1120310-最新台灣高血壓治療指引.pdf
1120310-最新台灣高血壓治療指引.pdf
 
Glucose Monitoring Smart Watch
Glucose Monitoring Smart WatchGlucose Monitoring Smart Watch
Glucose Monitoring Smart Watch
 
ADVANCE trial - Summary & Results
ADVANCE trial - Summary & ResultsADVANCE trial - Summary & Results
ADVANCE trial - Summary & Results
 
Timing dell' Ablazione della Fibrillazione atriale
Timing dell' Ablazione della Fibrillazione atrialeTiming dell' Ablazione della Fibrillazione atriale
Timing dell' Ablazione della Fibrillazione atriale
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
 
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
 
Automated Use of Clinical Laboratory Results
Automated Use of Clinical Laboratory ResultsAutomated Use of Clinical Laboratory Results
Automated Use of Clinical Laboratory Results
 
hypertension2016
hypertension2016hypertension2016
hypertension2016
 
Qualcomm Life Connect 2013 - Terrance H. Gregg
Qualcomm Life Connect 2013 - Terrance H. GreggQualcomm Life Connect 2013 - Terrance H. Gregg
Qualcomm Life Connect 2013 - Terrance H. Gregg
 
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervationPancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
 
Chapter 7_Health Screening Services in Community Pharmacy.pptx
Chapter 7_Health Screening Services in Community Pharmacy.pptxChapter 7_Health Screening Services in Community Pharmacy.pptx
Chapter 7_Health Screening Services in Community Pharmacy.pptx
 
2015 CHEP Hypertension Recommendations
2015 CHEP Hypertension Recommendations2015 CHEP Hypertension Recommendations
2015 CHEP Hypertension Recommendations
 

Mais de Joel Topf

Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014
Joel Topf
 
Creatine supplements
Creatine supplementsCreatine supplements
Creatine supplements
Joel Topf
 
Imaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patientsImaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patients
Joel Topf
 
AKI Lecture 2010
AKI Lecture 2010AKI Lecture 2010
AKI Lecture 2010
Joel Topf
 
The Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney DiseaseThe Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney Disease
Joel Topf
 
Electrolyte Vignette
Electrolyte VignetteElectrolyte Vignette
Electrolyte Vignette
Joel Topf
 
The Kidney and HIV
The Kidney and HIVThe Kidney and HIV
The Kidney and HIV
Joel Topf
 
HIV and the Kidney 2009
HIV and the Kidney 2009HIV and the Kidney 2009
HIV and the Kidney 2009
Joel Topf
 

Mais de Joel Topf (20)

Hyperkalemia, an update
Hyperkalemia, an updateHyperkalemia, an update
Hyperkalemia, an update
 
Low anion gap
Low anion gapLow anion gap
Low anion gap
 
Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014
 
Acute Kidney Injury 2013
Acute Kidney Injury 2013Acute Kidney Injury 2013
Acute Kidney Injury 2013
 
Creatine supplements
Creatine supplementsCreatine supplements
Creatine supplements
 
Social Media in Health Care
Social Media in Health CareSocial Media in Health Care
Social Media in Health Care
 
Imaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patientsImaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patients
 
AKI Lecture 2010
AKI Lecture 2010AKI Lecture 2010
AKI Lecture 2010
 
Uric Acid, Fructose and Hypertension
Uric Acid, Fructose and HypertensionUric Acid, Fructose and Hypertension
Uric Acid, Fructose and Hypertension
 
Hyponatremia
HyponatremiaHyponatremia
Hyponatremia
 
Diabetic Nephropathy 2009
Diabetic Nephropathy 2009Diabetic Nephropathy 2009
Diabetic Nephropathy 2009
 
Osmolar Gap
Osmolar GapOsmolar Gap
Osmolar Gap
 
Sodium dreadnaught
Sodium dreadnaughtSodium dreadnaught
Sodium dreadnaught
 
Electrolyte Free Water Clearance
Electrolyte Free Water ClearanceElectrolyte Free Water Clearance
Electrolyte Free Water Clearance
 
The Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney DiseaseThe Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney Disease
 
Whats New In Potassium
Whats New In PotassiumWhats New In Potassium
Whats New In Potassium
 
Lead Time Bias
Lead Time BiasLead Time Bias
Lead Time Bias
 
Electrolyte Vignette
Electrolyte VignetteElectrolyte Vignette
Electrolyte Vignette
 
The Kidney and HIV
The Kidney and HIVThe Kidney and HIV
The Kidney and HIV
 
HIV and the Kidney 2009
HIV and the Kidney 2009HIV and the Kidney 2009
HIV and the Kidney 2009
 

Último

Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
panagenda
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 

Último (20)

Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelNavi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 

Prescribing an app

  • 1. Take two apps and call me in the morning Prescribing code instead of pills, clinician perspective
  • 2.  Joel M Topf, MD  @Kidney_boy  @eajkd  www.Pbfluids.com
  • 5.
  • 6.
  • 7. UK Prospective Diabetes Study An intensive glucose control policy HbA1c 7.0 % vs 7.9 % reduces risk of ◦ any diabetes-related endpoints 12% p=0.030 ◦ microvascular endpoints 25% p=0.010 ◦ myocardial infarction 16% p=0.052 A tight blood pressure control policy 144/82 vs 154/87 mmHg reduces risk of ◦ any diabetes-related endpoint 24% p=0.005 ◦ microvascular endpoint 37% p=0.009 ◦ stroke 44% p=0.013 The benefit from tight glycemic control is less than the benefit from lousy blood pressure control
  • 8. Blood pressure control is more important blood sugar control
  • 9. 525,600minutes in a year minutes are assessed with office BP
  • 10. Gold standard for blood pressure assessment is 24-hour ambulatory blood pressure monitoring Patient assessed home blood pressures are more than twice as correlated than physician measured office blood pressures. Home 0.56 Office (MD) 0.21 Office (RN) 0.31 Little P, et al. BMJ. Aug 3 2002;325(7358):
  • 11. Home blood pressure readings are better than office readings at predicting end- organ damage (left ventricular hypertrophy, atherosclerosis), cardiovascular events and total mortality
  • 12. but this amazing technology is useless if you forget your numbers… …no patient ever forgets her phone
  • 13. Easiest blood pressure diary is the camera phone • No app to download • You already know how to use it • No cheating • Time and date stamped
  • 14.
  • 15. Can we go further?  Patients titrate insulin based on blood sugar  Can patients titrate antihypertensive medications based on blood pressure?
  • 16.
  • 17. 152.1 139 134.9 151.8 142.4 140.1 125 130 135 140 145 150 155 Baseline 6 Months 12 Months Systolic Blood Pressure Intervention Control 85 79.6 77.4 84.5 80.3 79.5 72 74 76 78 80 82 84 86 Baseline 6 Months 12 Months Diastolic Blood Pressure
  • 18. The intervention group  more medications prescribed (p=0.001) ◦ 0.3 at 6 months ◦ 0.4 at 12 months  fewer clinic visits (NS) ◦ 3.2 visits versus 3.5 for the control group  improved quality of life (NS)
  • 19.
  • 20. PatientswithEvents(%) 0 5 10 15 20 Years Post-Randomization 0 1 2 3 4 5 6 7 8 Primary Outcome Nonfatal MI, Nonfatal Stroke or CVD Death HR = 0.88 95% CI (0.73-1.06)
  • 21.
  • 22. We pay for tight blood pressure control with acute renal failure, hypotension and
  • 23. What I want in a prescription app  Public algorithm  Partners with the physician to choose the appropriate titration strategy  Validated  Approved